Butterfly Effect - Grow Ohio

In July 2026, Butterfly Effect - Grow Ohio concentrated 41.26% of sales in Flower and 33.96% in Vapor Pens, while Concentrates accounted for 10.80% of the mix; despite Flower’s -24.86% year-over-year contraction, month-over-month sales rose 9.49%, and Vapor Pens paired a -2.33% year-over-year dip with a 21.30% month-over-month increase. Concentrates advanced 14.40% year-over-year and 24.00% month-over-month, while Pre-Roll, though just 4.56% share, accelerated 67.83% month-over-month amid a lack of year-over-year comps; smaller formats were mixed, with Capsules down 35.12% year-over-year but up 36.27% month-over-month, and Tincture & Sublingual falling 17.24% month-over-month. The pattern indicates a reweighting toward faster-moving inhalable segments that can offset Flower’s drag, with category breadth cushioning the brand’s overall -10.59% year-over-year decline and positioning July’s momentum around Vapor Pens, Concentrates, and emerging Pre-Roll to carry incremental share.

With Flower ranked 10 in Ohio and carrying a premium average price of $44.26 versus the brand’s overall $31.17, the 9.49% month-over-month uptick suggests near-term volume elasticity, but the -24.86% year-over-year signal argues for deeper reliance on Vapor Pens’ 21.30% month-over-month growth and Concentrates’ 24.00% month-over-month surge to sustain baseline velocity. The divergence between Beverage (-12.13% year-over-year, 8.43% month-over-month) and Edible (-29.26% year-over-year, 6.61% month-over-month) versus the inhalable lift points to a portfolio where incremental gains are most efficiently captured by reinforcing inhalables while trimming exposure in slower oral formats; the implication is a positioning pivot that treats Flower as a traffic engine at a measured price stance, with Vapor Pens and Concentrates as the primary share acquisition vehicles in Ohio.